| Primary |
| Product Used For Unknown Indication |
12.2% |
| Tuberculosis |
11.9% |
| Urinary Tract Infection |
11.6% |
| Drug Use For Unknown Indication |
11.1% |
| Ulcerative Keratitis |
7.3% |
| Pelvic Inflammatory Disease |
6.5% |
| Pulmonary Tuberculosis |
6.5% |
| Preoperative Care |
4.6% |
| Abscess |
3.2% |
| Ear Infection |
3.2% |
| Prostatitis |
3.0% |
| Bronchopneumopathy |
2.7% |
| Postoperative Care |
2.7% |
| Prophylaxis |
2.7% |
| Typhoid Fever |
2.2% |
| Abscess Limb |
1.9% |
| Diarrhoea |
1.9% |
| Arthritis Bacterial |
1.6% |
| Bronchopulmonary Aspergillosis |
1.6% |
| Cardiovascular Disorder |
1.6% |
|
| Wrong Drug Administered |
10.8% |
| Suicidal Ideation |
8.4% |
| White Blood Cell Count Decreased |
7.2% |
| Drug Interaction |
6.0% |
| Tendon Pain |
6.0% |
| Arthropathy |
4.8% |
| Convulsion |
4.8% |
| Delusional Disorder, Mixed Type |
4.8% |
| Psychotic Disorder Due To A General Medical Condition |
4.8% |
| Shock |
4.8% |
| Toxic Anterior Segment Syndrome |
4.8% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Muscle Spasms |
3.6% |
| Palpitations |
3.6% |
| Renal Failure |
3.6% |
| Salivary Hypersecretion |
3.6% |
| Thrombocytopenia |
3.6% |
| Tremor |
3.6% |
| Ulcerative Keratitis |
3.6% |
|
| Secondary |
| Product Used For Unknown Indication |
44.9% |
| Drug Abuse |
11.9% |
| Drug Use For Unknown Indication |
9.6% |
| Tuberculosis |
3.5% |
| Hypertension |
3.2% |
| Infection |
3.0% |
| Pyrexia |
2.7% |
| Urinary Tract Infection |
2.5% |
| Keratitis Fungal |
2.1% |
| Prophylaxis |
2.1% |
| Ulcerative Keratitis |
1.9% |
| Cataract Operation |
1.8% |
| Constipation |
1.5% |
| Preoperative Care |
1.5% |
| Device Related Infection |
1.5% |
| Prostatitis |
1.5% |
| Glaucoma |
1.3% |
| Pain |
1.3% |
| Viral Infection |
1.2% |
| Pelvic Inflammatory Disease |
1.1% |
|
| Drug Rash With Eosinophilia And Systemic Symptoms |
18.6% |
| Thrombocytopenia |
10.4% |
| Vomiting |
5.5% |
| Drug Hypersensitivity |
4.9% |
| Corneal Deposits |
4.4% |
| Drug Interaction |
4.4% |
| Renal Failure Acute |
4.4% |
| Toxic Epidermal Necrolysis |
4.4% |
| Tumour Lysis Syndrome |
4.4% |
| Urticaria |
4.4% |
| Anaemia |
3.8% |
| Corneal Epithelium Defect |
3.8% |
| Toxic Anterior Segment Syndrome |
3.8% |
| Visual Acuity Reduced |
3.8% |
| Lymphopenia |
3.3% |
| Pancytopenia |
3.3% |
| Pseudomembranous Colitis |
3.3% |
| Tendonitis |
3.3% |
| Weight Decreased |
3.3% |
| Clostridium Difficile Colitis |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
34.4% |
| Drug Use For Unknown Indication |
16.3% |
| Hypertension |
8.3% |
| Rheumatoid Arthritis |
5.9% |
| Ill-defined Disorder |
5.6% |
| Urinary Tract Infection |
2.9% |
| Pulmonary Tuberculosis |
2.8% |
| Prophylaxis |
2.7% |
| Hiv Infection |
2.4% |
| Acute Lymphocytic Leukaemia |
2.2% |
| Pyrexia |
2.2% |
| Asthma |
2.0% |
| Diffuse Large B-cell Lymphoma |
1.7% |
| Tuberculosis |
1.7% |
| Conjunctivitis |
1.6% |
| Multiple Myeloma |
1.5% |
| Renal Transplant |
1.5% |
| Pain |
1.5% |
| Pneumonia |
1.5% |
| Crohn's Disease |
1.4% |
|
| Sepsis |
8.5% |
| Renal Failure Acute |
7.6% |
| Pyrexia |
7.1% |
| Septic Shock |
7.1% |
| Vomiting |
6.6% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.2% |
| Toxic Epidermal Necrolysis |
6.2% |
| Urinary Tract Infection |
5.7% |
| Rash |
4.7% |
| Weight Decreased |
4.7% |
| Off Label Use |
4.3% |
| Pneumonia |
4.3% |
| Malaise |
3.8% |
| Confusional State |
3.3% |
| Death |
3.3% |
| Hypersensitivity |
3.3% |
| Osteitis |
3.3% |
| Pruritus |
3.3% |
| Thrombocytopenia |
3.3% |
| Visual Acuity Reduced |
3.3% |
|
| Interacting |
| Product Used For Unknown Indication |
23.4% |
| Bronchitis |
9.4% |
| Nasopharyngitis |
9.4% |
| Ulcerative Keratitis |
9.4% |
| Depression |
6.3% |
| Psychotic Disorder |
6.3% |
| Atrial Fibrillation |
4.7% |
| Glaucoma |
4.7% |
| Type 2 Diabetes Mellitus |
4.7% |
| Urinary Tract Infection |
4.7% |
| Mood Altered |
3.1% |
| Deep Vein Thrombosis |
1.6% |
| Diarrhoea |
1.6% |
| Fungal Infection |
1.6% |
| Hypertension |
1.6% |
| Infection |
1.6% |
| Prophylaxis |
1.6% |
| Sepsis |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Urosepsis |
1.6% |
|
| International Normalised Ratio Increased |
35.7% |
| Drug Interaction |
21.4% |
| Syncope |
14.3% |
| Haemorrhage |
7.1% |
| Hypoglycaemia |
7.1% |
| Ulcerative Keratitis |
7.1% |
| Wrong Drug Administered |
7.1% |
|
